- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Melanoma in South Africa
Total 318 results
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
GlaxoSmithKlineCompletedMelanomaAustralia, United States
-
VicalCompletedRecurrent Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
Bristol-Myers SquibbNo longer availableMalignant MelanomaUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedMetastatic Cancer | Melanoma (Skin)United States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Cancer and Leukemia Group B; SWOG Cancer Research...CompletedMelanoma (Skin)United States
-
Bristol-Myers SquibbCompletedAdvanced Cutaneous MelanomaGermany, Poland, Spain, Australia, France, Argentina, Ireland, Israel, Belgium, United States, Switzerland, United Kingdom, Greece, Austria, Canada
-
Genentech, Inc.BioNTech SEActive, not recruitingAdvanced MelanomaUnited States, Spain, Belgium, Australia, Germany, United Kingdom
-
Canadian Cancer Trials GroupMelanoma and Skin Cancer Trials LimitedRecruitingUnresectable/Metastatic MelanomaCanada, Australia
-
Bristol-Myers SquibbActive, not recruitingUnresectable or Metastatic MelanomaUnited States, France, Poland, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, Germany, Ireland, Israel, Italy, Netherlands, New Zealand, Norway, Spain, Sweden, Switzerland, United Kingdom, Russian Federation
-
AstraZenecaCompletedRefractory MelanomaUnited States, Spain, Canada, France, Italy, United Kingdom, Argentina, Australia, Germany
-
National Cancer Institute (NCI)Active, not recruitingStage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Unresectable MelanomaUnited States
-
CelgeneUniversity of ArizonaCompletedMalignant MelanomaCanada, United States, Australia, United Kingdom, France, Italy, Spain, Germany, Netherlands
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV MelanomaUnited States
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingMalignant MelanomaUnited States, Australia, Austria, Brazil, Canada, Chile, China, France, Germany, Israel, Italy, Korea, Republic of, Poland, South Africa, Spain, Sweden, Switzerland, United Kingdom
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Spain, Hungary, Israel, United Kingdom, Australia, Austria, Belgium, Czechia, France, Germany, Italy, Netherlands, Russian Federation, Sweden, Switzerland, Canada, New Zealand, Norway
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Ludwig Institute for Cancer ResearchInstitute of Cancer Research, United KingdomCompletedMelanomaUnited Kingdom, Australia, New Zealand
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Cutaneous Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Recurrent Cutaneous Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Recurrent Mucosal Melanoma | Metastatic Mucosal Melanoma | Non-Cutaneous Melanoma | Metastatic Non-Cutaneous Melanoma | Recurrent Non-Cutaneous...United States, Canada, Ireland
-
Melanoma and Skin Cancer Trials LimitedNorfolk and Norwich University Hospitals NHS Foundation Trust; Canadian Cancer... and other collaboratorsRecruitingCutaneous Melanoma, Stage IIUnited States, Canada, United Kingdom, Australia, Italy, Sweden, Netherlands, New Zealand
-
BioVex LimitedAmgenCompletedMelanomaUnited States, United Kingdom, Canada, South Africa
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedN-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous MelanomaUnited States, Sweden, Australia, France, Italy, South Africa, Spain, United Kingdom, Germany, Netherlands, Israel, New Zealand, Belgium, Switzerland
-
AmgenMerck Sharp & Dohme LLCTerminatedMelanomaUnited States, Finland, France, Germany, Italy, Canada, Czechia, Poland, Switzerland, Korea, Republic of, Russian Federation, United Kingdom, Australia, Netherlands, Spain, Austria, Belgium, Hungary, Portugal, Greece, South Africa
-
GlaxoSmithKlineCompleted
-
National Cancer Institute (NCI)TerminatedRecurrent Melanoma | Stage IV Melanoma | Acral Lentiginous Malignant Melanoma | Lentigo Maligna Malignant Melanoma | Nodular Malignant Melanoma | Solar Radiation-related Skin Melanoma | Superficial Spreading Malignant MelanomaUnited States
-
PDL BioPharma, Inc.CompletedMelanoma | MetastasesUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Melanoma | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable Melanoma | Advanced Melanoma | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Southwest Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; Children... and other collaboratorsCompletedMelanoma (Skin)United States, Australia
-
Cancer Insight, LLCElios Therapeutics, LLCCompleted
-
National Cancer Institute (NCI)Active, not recruitingClinical Stage III Cutaneous Melanoma AJCC v8 | Mucosal Melanoma | Acral Lentiginous Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
Immunocore LtdRecruitingAdvanced MelanomaSpain, United States, Australia, Austria, Poland, France, Germany, Italy, Switzerland
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
AttenuonUnknown
-
Bristol-Myers SquibbMedarexCompletedMelanomaUnited States, Brazil, France, Italy, South Africa, United Kingdom, Argentina, Australia, Canada, Ireland, Israel, Russian Federation, Spain, Belgium, Germany, Portugal, Chile, Austria, Poland, Netherlands, Ukraine, Czech Republic, ... and more
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Recurrent Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingMalignant Melanoma Stage IIIUnited States, Netherlands, Australia
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Bristol-Myers SquibbCompletedMelanomaItaly, France, Spain, Australia
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingUnresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Melanoma of Unknown Primary | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingStage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable MelanomaUnited States
-
BayerAmgenCompletedMelanoma | CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)TerminatedMetastatic Cancer | Melanoma (Skin)United States
-
National Cancer Institute (NCI)Active, not recruitingStage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Melanoma | Lentigo Maligna Melanoma | Mucosal Melanoma | Acral Lentiginous Melanoma | Cutaneous Nodular Melanoma | Low-CSD MelanomaUnited States
-
Nektar TherapeuticsBristol-Myers SquibbTerminatedMelanoma | Melanoma (Skin) | Melanoma Stage IV | Melanoma Stage IIIUnited States, Spain, Germany, France, Australia, Italy, Greece, Israel, Russian Federation, New Zealand, Austria, United Kingdom, Netherlands, Portugal, Poland, Czechia, Romania
-
National Cancer Institute (NCI)Active, not recruitingStage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Melanoma | Stage IIIC Cutaneous Melanoma AJCC v7 | Melanoma of Unknown Primary | Stage IIIB Cutaneous Melanoma AJCC v7United States, Canada
-
Genzyme, a Sanofi CompanyCompletedMelanomaUnited States
-
AstraZenecaCompletedMelanomaUnited States, Italy, Spain, Sweden, Belgium, Canada, Poland, Switzerland, France, Russian Federation, United Kingdom, Australia, Argentina, Germany, Netherlands, Israel, South Africa, Austria, Greece, Mexico, Slovakia